Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.
Also called NCT01270867
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 178 participants
- Sponsor
- Registry
-
NCT01270867
-
- Main results
- Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial
- Other papers using this trial's data
- Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01270867. Randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2011-12 (actual). Results posted on 2014-02-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
- Acronym
- TREVO2
- Condition
- Ischemic Stroke
- Intervention (Device)
- Mechanical Thrombectomy
- Lead sponsor
- Stryker Neurovascular
Record details
- Record id
cardio:ct-nct01270867- Content hash
4a33ba69960fc2e3c1c861ddcc66a868da69767e8b0341f875c01a468a50bc86